“so in other words there is no license deal or other non dilutive deal for after approval.”
—Correct. There never will be. No big pharma is interested. That became clear when Roswell Park sold its tech pennies on dollar to NWBO because no one wanted it. All big pharma execs ran as fast and far away from LP as possible after May 2022 fiasco.
Market Data 
Markets 
AI
